Business Context and Reporting Period
Company: Merit Medical Systems, Inc. (MMSI)
Filing Type: Form 8-K (Current Report)
Date of Report: February 24, 2026
Reporting Period: Fourth Quarter and Full Year ended December 31, 2025
This filing announces the release of operating and financial results for the quarter and year ended December 31, 2025, and includes fiscal year 2026 guidance. The detailed financial data is contained in the press release (Exhibit 99.1) and conference call presentation (Exhibit 99.2) incorporated by reference.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached press release (Exhibit 99.1) and are not explicitly stated within the body of this Form 8-K.
Material Changes and Comparisons
The filing references the announcement of results for the quarter and year ended December 31, 2025, but does not detail specific material changes or percentage comparisons versus prior periods within the text of this report. Investors must refer to Exhibit 99.1 for comparative analysis.
Guidance, Outlook, and Management Commentary
- Guidance: The company issued fiscal year 2026 guidance in the accompanying press release.
- Non-GAAP Measures: Merit discloses non-GAAP financial information alongside GAAP results. Reconciliations are provided in the exhibits.
- Limitations on Guidance: Merit explicitly states it does not provide guidance for GAAP reported financial measures (other than revenue) or a reconciliation of forward-looking non-GAAP measures to GAAP. This is due to the inability to predict with reasonable certainty the impact of:
- Acquisition-related expenses.
- Non-cash expenses (amortization/write-offs of assets).
- Severance and performance-based stock compensation.
- Litigation, administrative proceedings, and settlements.
- Changes in governmental or industry regulations.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and Full Year 2025 revenue, earnings, and cash flow figures.
- Examine the non-GAAP to GAAP reconciliations in Exhibit 99.1 to understand adjustments made to reported earnings.
- Verify the specific Fiscal Year 2026 revenue guidance provided in the press release, noting the absence of GAAP profit guidance.
- Assess the potential impact of litigation and regulatory changes on future results, as management cites these as unpredictable variables affecting GAAP guidance.
- Listen to the conference call or review Exhibit 99.2 for management's qualitative commentary on the results.